Assessment of Cost-Effectiveness Models for Biologics in the Management of Severe Ankylosing Spondylitis

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.2223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV